ArticleScandinavian journal of medicine & science in sports2026
Effect of Age and Sex on Lower Extremity Power Production Capacity Throughout the Lifespan Based on 30 217 Finnish Participant Data.
Article in Scandinavian journal of medicine & science in sports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study examined lower-extremity power using countermovement jump (CMJ) height and estimated peak power across the lifespan with five Finnish datasets. The pooled dataset included 24 804 males and 5413 females aged 6-75 years. CMJ height (cm) was measured on a contact mat from flight time(s), and peak power (W) was estimated using equations for adults and children and expressed also relative to body mass (W/kg). Five-year age groups were formed for mean comparison. CMJ height and peak power increased throughout childhood and adolescence. From ages 11 to 15, males exhibited greater CMJ height and peak power than females. Based on mean values, CMJ height peaked at ages 16-20 and peak power at 21-25 in males, while both peaked at 21-25 in females. Males maintained their level until 26-30 years, whereas females showed a decline after the peak. Segmented regression models indicated earlier peaks for CMJ height (18 years in males, 17 in females) and slightly later peaks for peak power (21 years in males, 19 in females). Before the peaking age, annual relative increases calculated over 11-15 years were 5.6% versus 3.1% for CMJ height and 4.7%-7.6% vs. 4.0%-7.3% for peak power (males vs. females). After the peaking age, annual declines calculated over 52-58 years were 0.9% for CMJ height and 0.3%-0.7% for peak power in both sexes. The results provide insights into life-course patterns and the transitional period of late adolescence and early adulthood, when jumping performance peaks and evidence is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.